Biomarkers for Intestinal Permeability
NCT04667208 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51
Last updated 2021-01-26
Summary
This study aims to find easy-to-measure biomarkers of intestinal permeability as surrogate markers for effortful "gold standard" methods.
Conditions
- Focus: Simplified Method to Assess Intestinal Permeability
Sponsors & Collaborators
-
University of Hohenheim
lead OTHER
Principal Investigators
-
Stephan C Bischoff, Prof. Dr. · University of Hohenheim, Institute of Nutritional Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2020-12-01
- Completion
- 2021-01-07
Countries
- Germany
Study Locations
More Related Trials
-
A Study of the Intestinal Microbiome in Patients with Cirrhosis
NCT06808698 ·Status: NOT_YET_RECRUITING
-
The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
NCT07015580 ·Status: RECRUITING
-
Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
NCT03060252 ·Status: UNKNOWN
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED
-
Syndecan 1 as Biomarker for Inflammation
NCT02333526 ·Status: UNKNOWN
-
Plasma Citrulline Concentration in Tropical Enteropathy
NCT00816842 ·Status: COMPLETED
-
Intestinal Barrier Function and Liver Cirrhosis
NCT01081236 ·Status: UNKNOWN
-
Prediction of Acute Pancreatitis Outcome
NCT06653205 ·Status: NOT_YET_RECRUITING
-
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
NCT06250309 ·Status: RECRUITING ·Phase: NA
-
Characterization of the Immunometabolic Signature in Long COVID-19.
NCT05758480 ·Status: COMPLETED ·Phase: NA
-
Study and Analysis of Acute Pancreatitis Complicated With COVID-19
NCT05722678 ·Status: UNKNOWN
-
Diagnostic and Prognostic Biomarkers in SARS-CoV-2 Infections
NCT06774638 ·Status: COMPLETED
-
Autoimmune Hepatitis Cohort in China
NCT05785793 ·Status: RECRUITING
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
NCT02778464 ·Status: COMPLETED
-
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
NCT03841318 ·Status: COMPLETED ·Phase: NA
-
Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis
NCT04195724 ·Status: UNKNOWN ·Phase: NA
-
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease
NCT07284862 ·Status: COMPLETED
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene
NCT03830073 ·Status: UNKNOWN
-
Identification of New Markers in the Hypereosinophilic Syndrome
NCT01713504 ·Status: COMPLETED ·Phase: NA
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Inflammatory Marker in Ibd and Peripheral Arthritis
NCT05705232 ·Status: UNKNOWN
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis
NCT05565885 ·Status: RECRUITING